Georges Philippe P.
- Country
- France
- Department
- Hepatology
Research Overview
- HepaStem Long-Term Safety Registry – Registry for Patients who have been administered HepaStem
- Efficacy of Bezafibrate in Primary Sclerosing Cholangitis with Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Human Albumin Solution on Acute Kidney Injury Incidence Post-Liver Transplantation
Data & Insights
Has run more than one trial at 10 of 46 partner sites.
Specializations
Hepatic Disorders
This investigator specializes in treating primary sclerosing cholangitis, focusing on innovative therapeutic approaches for patients with persistent cholestasis. Their research encompasses the evaluation of treatment combinations including ursodeoxycholic acid therapy and other potential therapeutic agents.
- Cholestatic Liver Disease Management
- Bile Duct Disorders
Transplant Medicine
The investigator has significant expertise in liver transplantation and post-transplant care. Their work includes the optimization of immunosuppressive therapy regimens and exploration of novel medication administration strategies for transplant recipients.
- Post-Transplant Care
- Immunosuppressive Protocols
Cell-Based Therapies
The investigator explores advanced therapeutic applications in stem cell treatments for various hepatic conditions. Their research includes long-term safety assessments of cell-based therapies for patients with urea cycle disorders, Crigler-Najjar syndrome, and fibroinflammatory liver diseases.
- Regenerative Medicine
- Rare Liver Disorders
- Long-term Safety Studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.